Literature DB >> 30002072

Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.

M Giray Ersoz1, Serra Arf1, Mumin Hocaoglu1, Isil Sayman Muslubas1, Murat Karacorlu2.   

Abstract

AIMS: To determine the demographic and morphological characteristics of patients with central serous chorioretinopathy (CSC) and describe risk factors for CSC.
METHODS: We retrospectively reviewed medical records of 811 patients with CSC and 816 healthy controls referred from 2002 to 2018.
RESULTS: The female/male ratio of patients with CSC was 1/2.7. Mean age of onset was 45.2 years. The peak prevalence for men occurred at 45-49 years. Women had two prevalence peaks, the higher at 55-59 years and the other at 45-49 years. Of these patients, 56.8% had unilateral disease, 42.1% had bilateral disease and 1.1% had only one eye. 671 (82.7%) patients had spectral domain optical coherence tomography (SD-OCT) images and 598 (73.7%) had enhanced depth choroidal images. Pigment epithelial detachment (PED) was detected in 763 (80.7%) of 945 eyes with SD-OCT images. Chronic cases were more likely to be bilateral and multifocal and to have PED (all p<0.001). Subfoveal choroidal thickness (SFCT) did not differ between chronic and classic cases (p=0.74), but SFCT was greater in multifocal cases than unifocal cases (p<0.001). In multivariate regression analyses, older age of onset, longer duration of disease and hyperopia were positively associated with having chronic disease rather than classic disease, and myopia and thyroid hormone replacement were negatively associated. Steroid use, antidepressant or anxiolytic drug use, smoking, pregnancy and hyperopia were risk factors, and myopia was a protective factor for CSC.
CONCLUSION: This is the largest case-control study of CSC to evaluate demographic morphological characteristics and risk factors. Multiple factors are associated with CSC. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  central serous chorioretinopathyzzm321990; choroidal thickness; chronic; multifocal; retinal pigment epithelium detachment; risk factors

Year:  2018        PMID: 30002072     DOI: 10.1136/bjophthalmol-2018-312431

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.

Authors:  Helena M A Feenstra; Elon H C van Dijk; Thomas J van Rijssen; Roula Tsonaka; Roselie M H Diederen; Carel B Hoyng; Reinier O Schlingemann; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-07       Impact factor: 3.535

2.  Distinct characteristics of central serous chorioretinopathy according to gender.

Authors:  Seigo Yoneyama; Ayumi Fukui; Yoichi Sakurada; Nobuhiro Terao; Taiyo Shijo; Natsuki Kusada; Atsushi Sugiyama; Mio Matsubara; Yoshiko Fukuda; Wataru Kikushima; Ravi Parikh; Fumihiko Mabuchi; Chie Sotozono; Kenji Kashiwagi
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

3.  Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.

Authors:  Izabella Karska-Basta; Weronika Pociej-Marciak; Michał Chrząszcz; Katarzyna Żuber-Łaskawiec; Marek Sanak; Bożena Romanowska-Dixon
Journal:  Arch Med Sci       Date:  2020-01-29       Impact factor: 3.318

4.  Prevalence of and factors associated with dilated choroidal vessels beneath the retinal pigment epithelium among the Japanese.

Authors:  Yasuki Ito; Mari Ito; Takeshi Iwase; Keiko Kataoka; Kazuhisa Yamada; Sayuri Yasuda; Hiroki Ito; Jun Takeuchi; Yuyako Nakano; Ai Fujita; Etsuyo Horiguchi; Yosuke Taki; Hiroshi Yatsuya; Hiroko Terasaki
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

5.  Correlation between choroidal structure and smoking in eyes with central serous chorioretinopathy.

Authors:  Kazuyoshi Okawa; Tatsuya Inoue; Ryo Asaoka; Keiko Azuma; Ryo Obata; Rei Arasaki; Shouko Ikeda; Arisa Ito; Maiko Maruyama-Inoue; Yasuo Yanagi; Kazuaki Kadonosono
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

6.  Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.

Authors:  Jia Yu; Gezhi Xu; Qing Chang; Xiaofeng Ye; Lei Li; Chunhui Jiang; Qi Zhao
Journal:  J Ophthalmol       Date:  2019-08-14       Impact factor: 1.909

7.  Visual and anatomical outcomes of central serous chorioretinopathy patients presenting to a tertiary unit: a prospective analysis.

Authors:  Andrew Walkden; Olivia Atkinson; Emma Linton; Adam Bull; Laina Abraham; Ramandeep Chhabra
Journal:  Ther Adv Ophthalmol       Date:  2020-05-29

8.  A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.

Authors:  Yun Ji Lee; Yeon Jeong Lee; Jae Yeon Lee; Suhwan Lee
Journal:  Sci Rep       Date:  2021-03-12       Impact factor: 4.379

9.  Central Serous Chorioretinopathy Classification.

Authors:  Manuel Vilela; Carolina Mengue
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-30

10.  Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium.

Authors:  Hakan Kaymak; Saskia Funk; Andreas Fricke; Roxana Fulga; Karsten Klabe; Berthold Seitz; Achim Langenbucher; Hartmut Schwahn
Journal:  Int J Retina Vitreous       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.